EGFR and neoplasm: Notably, EGFR signalling has also been found to regulate E-cadherin expression and function in tumour cells through inhibiting its transcription and promoting its cleavage, degradation and endocytosis [34–39], suggesting a feedback regulation between E-cadherin and EGFR signalling.